Phenytoin sodium 100 mg Extended Release Oral Capsule
RxNorm 855671
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 855671 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: phenytoin sodium 100 mg Extended Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Phenytoin sodium 100 mg Extended Release Oral Capsule
(Atom ID: 12348644)
SYPrescribable
Synonym (SY):
DPH sodium 100 mg Extended Release Oral Capsule
(Atom ID: 6357884)
PSNPrescribable
Prescribable Name (PSN):
Phenytoin sodium 100 mg Extended Release Oral Capsule
(Atom ID: 6366903)
PTPrescribable
Designated preferred name (PT):
Phenytoin sodium 100 mg prolonged-release oral capsule
(Atom ID: 10303188)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely phenytoin sodium 100 mg/1 each prolonged-release oral capsule (clinical drug)
(Atom ID: 10316183)
Patient Education
Phenytoin
Phenytoin is used to control certain type of seizures, and to treat and prevent seizures that may begin during or after surgery to the brain or nervous system. Phenytoin is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.